Atherosclerosis

Pathophysiology, prevention, and management of arterial disease.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
CardiologyVascular SurgeryEndocrinology

Clinical Guidelines

ESVS 2023 Management Guidelines of Atherosclerotic Carotid and Vertebral Artery Disease
National
NICE guideline [NG238]: Cardiovascular disease: risk assessment and reduction, including lipid modification
National
SIGN 149: Risk estimation and the prevention of cardiovascular disease
National
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease
Local
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
Local
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease
Local
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: New Treatments and Clinical Guidance
Local
2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias
Local
Defining Severe Familial Hypercholesterolaemia: A Consensus Statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel
Local
European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery Disease
Local
Fasting Not Routinely Required for Determination of a Lipid Profile: Consensus Statement From the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
Local
International Atherosclerosis Society Guidance for Implementing Best Practice in the Care of Familial Hypercholesterolaemia
Local
Lipoprotein(a) in Atherosclerotic Cardiovascular Disease and Aortic Stenosis: A European Atherosclerosis Society Consensus Statement (2022)
Local